Michael S. Maddux

672 total citations
26 papers, 529 citations indexed

About

Michael S. Maddux is a scholar working on Pharmacology, Transplantation and Surgery. According to data from OpenAlex, Michael S. Maddux has authored 26 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Transplantation and 6 papers in Surgery. Recurrent topics in Michael S. Maddux's work include Renal Transplantation Outcomes and Treatments (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Drug-Induced Adverse Reactions (4 papers). Michael S. Maddux is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Drug-Induced Adverse Reactions (4 papers). Michael S. Maddux collaborates with scholars based in United States. Michael S. Maddux's co-authors include Raymond Pollak, Steven L. Barriere, Martin F. Mozes, M Morán, Beverley L. Ketel, Carl B. Wallemark, Olga Jonasson, Mark S. Paller, Scott A. Gruber and P. Jan Geiseler and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and The Journal of Urology.

In The Last Decade

Michael S. Maddux

26 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Maddux United States 12 153 109 91 89 88 26 529
Karl R. Brinker United States 13 248 1.6× 244 2.2× 91 1.0× 36 0.4× 51 0.6× 24 712
K. Sack Germany 13 58 0.4× 51 0.5× 135 1.5× 143 1.6× 156 1.8× 76 620
Vincent P. Gotz United States 13 91 0.6× 47 0.4× 101 1.1× 43 0.5× 76 0.9× 50 557
Miguel Moysés Neto Brazil 16 76 0.5× 58 0.5× 48 0.5× 31 0.3× 129 1.5× 62 767
Mariadelfina Molinaro Italy 13 83 0.5× 145 1.3× 187 2.1× 102 1.1× 123 1.4× 26 505
Qiquan Wan China 15 122 0.8× 110 1.0× 85 0.9× 116 1.3× 272 3.1× 56 615
Sun Ae Yoon South Korea 20 258 1.7× 62 0.6× 88 1.0× 26 0.3× 84 1.0× 56 996
Elizabeth Cohen United States 14 164 1.1× 62 0.6× 147 1.6× 42 0.5× 103 1.2× 44 845
Jaime Aranda‐Michel United States 18 489 3.2× 109 1.0× 99 1.1× 28 0.3× 251 2.9× 49 919
Estela Monteiro Portugal 15 109 0.7× 33 0.3× 104 1.1× 22 0.2× 168 1.9× 52 668

Countries citing papers authored by Michael S. Maddux

Since Specialization
Citations

This map shows the geographic impact of Michael S. Maddux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Maddux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Maddux more than expected).

Fields of papers citing papers by Michael S. Maddux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Maddux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Maddux. The network helps show where Michael S. Maddux may publish in the future.

Co-authorship network of co-authors of Michael S. Maddux

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Maddux. A scholar is included among the top collaborators of Michael S. Maddux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Maddux. Michael S. Maddux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rouse, Michael J. & Michael S. Maddux. (2010). Conceptual framework for pharmacists’ professional development: Implications for future planning. Journal of the American Pharmacists Association. 50(3). 343–346. 4 indexed citations
2.
Maddux, Michael S., et al.. (1998). Introductory Clinical Clerkship During the First and Second Professional Years: Emphasis in Clinical Practice and Writing. American Journal of Pharmaceutical Education. 62(1). 53–61. 10 indexed citations
3.
Maddux, Michael S., et al.. (1998). The Peripheral Brain: A Tool To Foster Higher-Order Thinking in Abilities-Based Courses. American Journal of Pharmaceutical Education. 62(1). 44–49. 3 indexed citations
4.
Lee, Mary, Marie A. Abate, Nancy Fjortoft, Annē Linn, & Michael S. Maddux. (1995). Report of the Task Force on the Recruitment and Retention of Pharmacy Practice Faculty. American Journal of Pharmaceutical Education. 59. 28S–33S. 2 indexed citations
5.
Pollak, Raymond, et al.. (1993). A RANDOMIZED DOUBLE-BLIND TRIAL OF THE USE OF HUMAN RECOMBINANT SUPEROXIDE DISMUTASE IN RENAL TRANSPLANTATION. Transplantation. 55(1). 57–60. 50 indexed citations
6.
Vasquez, Eva M., et al.. (1993). HIGH-DOSE ORAL ACYCLOVIR PROPHYLAXIS FOR PRIMARY CYTOMEGALOVIRUS INFECTION IN SERONEGATIVE RENAL ALLOGRAFT RECIPIENTS. Transplantation. 55(2). 448–449. 17 indexed citations
7.
Pollak, Raymond, Richard J. Knight, Martin F. Mozes, et al.. (1992). A Trial of the Prostaglandin E1 Analogue, Enisoprost, to Reverse Chronic Cyclosporine-Associated Renal Dysfunction. American Journal of Kidney Diseases. 20(4). 336–341. 12 indexed citations
8.
Schrader, Bruce J., et al.. (1991). Digoxin‐Like Immunoreactive Substance in Renal Transplant Patients. The Journal of Clinical Pharmacology. 31(12). 1126–1131. 4 indexed citations
9.
Maddux, Michael S.. (1991). Effects of ß‐Lactamase‐Mediated Antimicrobial Resistance: The Role of ß‐Lactamase Inhibitors. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 11(2P2). 8 indexed citations
10.
Pollak, Raymond, et al.. (1991). Utility of an in vitro immunoassay to guide immunosuppressive therapy.. PubMed. 23(1 Pt 2). 1113–4. 7 indexed citations
11.
Morán, M, Martin F. Mozes, Michael S. Maddux, et al.. (1990). Prevention of Acute Graft Rejection by the Prostaglandin E1Analogue Misoprostol in Renal-Transplant Recipients Treated with Cyclosporine and Prednisone. New England Journal of Medicine. 322(17). 1183–1188. 114 indexed citations
12.
Pollak, Raymond, et al.. (1990). THE IMMUNOSUPPRESSIVE PROPERTIES OF NEW ORAL PROSTAGLANDIN E1 ANALOGS. Transplantation. 50(5). 834–838. 22 indexed citations
13.
Maddux, Michael S., et al.. (1989). Effective prophylaxis of early post-transplant urinary tract infections (UTI) in the cyclosporine (CSA) era.. PubMed. 21(1 Pt 2). 2108–9. 10 indexed citations
14.
Maddux, Michael S., et al.. (1989). Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy.. PubMed. 21(1 Pt 2). 1758–60. 11 indexed citations
15.
Maddux, Michael S., et al.. (1989). Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.. PubMed. 21(1 Pt 2). 1276–7. 19 indexed citations
16.
Maddux, Michael S., et al.. (1989). Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.. PubMed. 21(1 Pt 2). 1476–7. 4 indexed citations
17.
Maddux, Michael S., et al.. (1987). Optimizing cyclosporine use in pediatric patients by measuring pretransplant blood levels.. PubMed. 19(1 Pt 2). 1709–10. 4 indexed citations
18.
Prasad, Rameshwar, et al.. (1985). A significant difference in cyclosporine blood and plasma concentrations with heparin or EDTA anticoagulant.. PubMed. 39(6). 667–9. 3 indexed citations
19.
Geiseler, P. Jan, et al.. (1985). Dosage of antituberculous drugs in obese patients.. PubMed. 131(6). 944–6. 21 indexed citations
20.
Maddux, Michael S. & Steven L. Barriere. (1980). A Review of Complications of Amphotericin-B Therapy: Recommendations for Prevention and Management. Drug Intelligence & Clinical Pharmacy. 14(3). 177–181. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl R. Brinker Breakdown of academic impact, for papers by K. Sack Breakdown of academic impact, for papers by Vincent P. Gotz Breakdown of academic impact, for papers by Miguel Moysés Neto Breakdown of academic impact, for papers by Mariadelfina Molinaro Breakdown of academic impact, for papers by Qiquan Wan Breakdown of academic impact, for papers by Sun Ae Yoon Breakdown of academic impact, for papers by Elizabeth Cohen Breakdown of academic impact, for papers by Jaime Aranda‐Michel Breakdown of academic impact, for papers by Estela Monteiro
Rankless by CCL
2026